NOTCH3 pathway activation in HGSOC correlates with ovarian cancer progression [75, 76] and contributes to epithelial-mesenchymal transition (EMT) and chemoresistance [74, 77]. This evidence concerns the gene NOTCH3 and ovarian carcinoma.